The Ohio State University College of Medicine recently announced a partnership with Medtronic, a leader in medical technology, to establish a long-term strategic collaboration focused on executing value-based health care initiatives across neurosciences and spine.

“While the partnership between Medtronic and The Ohio State University College of Medicine is in its early stages, there are two initial areas of focus,” says Peter Mohler, PhD, chief scientific officer at The Ohio State University Wexner Medical Center. “We want to generate better clinical insights into existing and promising new therapy approaches through collaborative innovation and research programs, and to use data and process improvement to create efficiencies and optimize the delivery of care.”

This is one of several commercial partnerships in which Ohio State College of Medicine is participating to expand research efforts and raise the level of innovation in health care. 

“We see a lot of potential in having this kind of relationship with Medtronic,” said Andrew Thomas, MD, chief clinical officer at Ohio State Wexner Medical Center. “We believe the partnership will lead to innovative programs that will enhance the care we provide our patients.”

Headquartered in Dublin, Ireland, Medtronic is among the world’s largest medical technology, services and solutions companies—alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries.

“The real-world insights resulting from this partnership have the potential to help improve the lives of patients suffering from a variety of neurological and spine conditions,” said Sean Haag, vice president of Strategic Alliances with Medtronic’s Restorative Therapies Group. “The (Ohio State) College of Medicine’s expertise in neuroscience and spine disorders provides opportunities for us to better understand the potential for current technologies, explore promising new ideas for existing therapies or possibly even develop new therapies that expand health care access in a more cost-effective way.”

“We are very excited about this partnership,” said Russell Lonser, MD, chair of the Department of Neurological Surgery at Ohio State College of Medicine. “Both the College of Medicine and Medtronic have expertise in specific areas of health care. By working together, we can combine our expertise in real-world settings to find new solutions and deliver better outcomes in patient care.